307 related articles for article (PubMed ID: 6309451)
1. Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
Stuart-Harris RC; Mooney CA; Smith IE
Clin Oncol; 1983 Jun; 9(2):143-6. PubMed ID: 6309451
[TBL] [Abstract][Full Text] [Related]
2. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of refractory cytostatic agent-induced vomiting with the synthetic cannabinoid levonantradol].
Heim ME; Queisser W
Onkologie; 1982 Apr; 5(2):94-6. PubMed ID: 7048169
[TBL] [Abstract][Full Text] [Related]
4. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
5. Levonantradol for the treatment of chemotherapy-induced nausea and vomiting.
Gerhartz HH; Binsack T; Hiller E
Klin Wochenschr; 1983 Jul; 61(14):719-21. PubMed ID: 6350696
[TBL] [Abstract][Full Text] [Related]
6. Levonantradol effectiveness in cancer patients resistant to conventional anti-emetics.
Kenny JB; Wilkinson PM
Clin Oncol; 1982 Dec; 8(4):335-9. PubMed ID: 7168926
[No Abstract] [Full Text] [Related]
7. Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy.
Joss RA; Galeazzi RL; Bischoff A; Do DD; Goldhirsch A; Brunner KW
Cancer Chemother Pharmacol; 1982; 9(1):61-4. PubMed ID: 7139853
[TBL] [Abstract][Full Text] [Related]
8. Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.
Heim ME; Queisser W; Altenburg HP
Cancer Chemother Pharmacol; 1984; 13(2):123-5. PubMed ID: 6467496
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of aprepitant in management of chemotherapy-induced nausea and vomiting.
Osorio-Sanchez JA; Karapetis C; Koczwara B
Intern Med J; 2007 Apr; 37(4):247-50. PubMed ID: 17388865
[TBL] [Abstract][Full Text] [Related]
10. Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine.
Sheidler VR; Ettinger DS; Diasio RB; Enterline JP; Brown MD
J Clin Pharmacol; 1984 Apr; 24(4):155-9. PubMed ID: 6373843
[TBL] [Abstract][Full Text] [Related]
11. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
12. Management of nausea and vomiting caused by anticancer drugs: state of the art.
Pisters KM; Kris MG
Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744
[TBL] [Abstract][Full Text] [Related]
13. Synthetic marijuana for nausea and vomiting due to cancer chemotherapy.
Med Lett Drugs Ther; 1985 Nov; 27(701):97-8. PubMed ID: 2999571
[No Abstract] [Full Text] [Related]
14. An audit of chemotherapy-induced nausea and vomiting in children.
Clinton F; Dowling M; Capra M
Nurs Child Young People; 2012 Sep; 24(7):18-23. PubMed ID: 23155937
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
Goodman M
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with levonantradol hydrochloride in the prevention of cancer chemotherapy-induced nausea and vomiting.
Heim ME; Romer W; Queisser W
J Clin Pharmacol; 1981; 21(S1):86S-89S. PubMed ID: 7298877
[TBL] [Abstract][Full Text] [Related]
17. A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy.
Hutcheon AW; Palmer JB; Soukop M; Cunningham D; McArdle C; Welsh J; Stuart F; Sangster G; Kaye S; Charlton D
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1087-90. PubMed ID: 6352278
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of malignant tumors, vomiting and nausea--what to do?].
Ell C; König HJ
Fortschr Med; 1984 Oct; 102(37):913-5. PubMed ID: 6500448
[TBL] [Abstract][Full Text] [Related]
19. Levonantradol for chemotherapy-induced emesis: phase I-II oral administration.
Laszlo J; Lucas VS; Hanson DC; Cronin CM; Sallan SE
J Clin Pharmacol; 1981; 21(S1):51S-56S. PubMed ID: 7298875
[TBL] [Abstract][Full Text] [Related]
20. [The use of antiemetics in cancer chemotherapy].
Ghosn M; Droz JP
J Med Liban; 1992; 40(2):106-7. PubMed ID: 1339878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
